| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.084 | 0.6 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |